CLPT - Company ID 0001285550
The table below shows ClearPoint Neuro, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$7.97M | -$6.17M | -$3.84M | -$5.68M | -$4.27M | -$2.13M |
| Capital expenditure | $645.00K | $183.00K | $0.00 | $138.00K | $69.00K | $40.00K |
| Investing cash flow | -$645.00K | -$183.00K | $0.00 | -$138.00K | -$185.00K | -$40.00K |
| Dividends paid | - | - | - |
ClearPoint Neuro, Inc. reported operating cash flow of -$23.90M for fiscal year 2025. That is down 167.0% from -$8.95M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$5.82M (FY 2016) to -$23.90M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | -$1.84M | -$1.36M | $16.05M | -$5.00K | $3.00K | $46.93M |